ARK Genomic Revolution ETF
ARKG
4 hedge funds and large institutions have $689K invested in ARK Genomic Revolution ETF in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
18% more capital invested
Capital invested by funds: $586K → $689K (+$103K)
0.96% less ownership
Funds ownership: 7.51% → 6.55% (-0.96%)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$225K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$193K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$29K |
| 3 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
-$19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $317K | -$193K | -10,116 | -40% |
|
|
2
LPL Financial
San Diego,
California
| $241K | +$225K | +11,769 | New |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $71K | – | – | – |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $60K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$29K | -1,684 | Closed |
|
|
HFM
6
Hartford Financial Management
Hartford,
Connecticut
| – | -$19K | -1,099 | Closed |
|
ARKG Hedge Fund Activity: Q1 2017 in Review
4 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2017, worth a combined $689K — up 18% from $586K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ARKG and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was LPL Financial, opening a new position worth an estimated $225K. The largest seller was Jane Street, cutting an estimated $193K.
- 4 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2017, down from 5 in Q4 2016.
- Funds reported $689K of ARK Genomic Revolution ETF stock for Q1 2017, up 18% quarter-over-quarter.
- 1 fund opened new ARK Genomic Revolution ETF positions in Q1 2017 and 2 closed out, a net change of -1 holder.
- The largest ARK Genomic Revolution ETF buyer in Q1 2017 was LPL Financial, an estimated $225K added.
- The largest ARK Genomic Revolution ETF seller in Q1 2017 was Jane Street, an estimated $193K sold.
Based on aggregated 13F filings for Q1 2017.